Natural history and screening model for high‐risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands
Open Access
- 1 February 2005
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 115 (2) , 268-275
- https://doi.org/10.1002/ijc.20846
Abstract
A simulation model is presented that assumes that persistent infection with high‐risk human papillomavirus (hrHPV) is a necessary cause of cervical cancer. For the estimation of the model parameters, data of recent Dutch follow‐up studies were reanalyzed. The predicted incidences of cervical cancer, cervical intraepithelial neoplasia (CIN1, CIN2 and CIN3) and abnormal cytology were validated with nationwide figures and population‐based screening results. The model predicted a lifetime risk for cervical cancer of 2.9% with a peak at age 48 years. The predicted lifetime risk dropped to 0.4% when attending cervical screening. For women who were not hrHPV infected at 30 years, the lifetime risk was 1.6%. Sensitivity analyses were performed to check natural history assumptions that were only weakly identified from available data sets. The incidence of CIN3 observed with screening appeared a useful clinical end point as the predicted incidence was robust against changes in the sensitivity of cervical cytology and the duration to CIN3. The model can be used to study the health‐economic benefits that can be achieved in nationwide screening when including an hrHPV test.Keywords
This publication has 53 references indexed in Scilit:
- Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial NeoplasiaJNCI Journal of the National Cancer Institute, 2004
- POBASCAM, a population‐based randomized controlled trial for implementation of high‐risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 womenInternational Journal of Cancer, 2004
- Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patientsBritish Journal of Cancer, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Incidence, Prevalence, and Clearance of Type‐Specific Human Papillomavirus Infections: The Young Women’s Health StudyThe Journal of Infectious Diseases, 2002
- Criteria for Organized Cervical Screening ProgramsActa Cytologica, 2002
- High‐risk HPV testing in women with borderline and mild dyskaryosis: long‐term follow‐up data and clinical relevanceThe Journal of Pathology, 2001
- PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changesJournal of Clinical Pathology, 2000
- An Introduction to Markov Modelling for Economic EvaluationPharmacoEconomics, 1998
- Natural History of Cervical Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1993